The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model

被引：0
|
作者：
Kwon, Hyuk-Sang
Hong, Oak-Kee
Ko, Seung-Hyun
Choi, Yoon-Hee
Lee, Sung-Soo
Son, Tae-Seo
Moon, Sung-Dae
Yoo, Soon-Jib
Son, Hyun-Sik
Yoon, Kun-Ho
Cha, Bong-Yun
Son, Ho-Young
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [21] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    L. R. Whitfield
    R. H. Stern
    A. J. Sedman
    R. Abel
    D. M. Gibson
    European Journal of Drug Metabolism and Pharmacokinetics, 2000, 25 : 97 - 101
  • [22] Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase
    Whitfield, LR
    Stern, RH
    Sedman, AJ
    Abel, R
    Gibson, DM
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2000, 25 (02) : 97 - 101
  • [23] Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes
    Chaiyakunapruk, N
    Boudreau, D
    Ramsey, SD
    JOURNAL OF CARDIOVASCULAR RISK, 2001, 8 (03): : 127 - 132
  • [24] HMG-CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis
    Paintlia, AS
    Paintlia, MK
    Khan, M
    Vollmer, T
    Singh, AK
    Singh, I
    FASEB JOURNAL, 2005, 19 (11): : 1407 - 1421
  • [25] Pitavastatin (a HMG-CoA reductase inhibitor) facilitates insulin-induced glucose metabolism in human hepatoma cells
    Yamauchi, K
    Nakamura, J
    Takeuchi, Y
    Shigematsu, S
    Hashizume, K
    DIABETES, 2004, 53 : A324 - A324
  • [26] HMG-COA reductase inhibitor cerivastatin lowers advanced glycosylation end-products in patients with type 2 diabetes
    Scharnagl, H
    Stojakovic, T
    Winkler, K
    März, W
    Boehm, B
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 78 - 78
  • [27] Comparison in patients with type 2 diabetes of fibric acid versus HMG-CoA reductase inhibitor treatment of combined dyslipidemia
    McLaughlin, TL
    Abbasi, F
    Lamendola, CA
    Leary, E
    Reaven, GM
    DIABETES, 2002, 51 : A495 - A496
  • [28] Topiramate improves glucose tolerance and may improve insulin sensitivity in animal models of type 2 diabetes mellitus
    Demarest, K
    Conway, B
    Osborne, M
    Chen, XL
    DIABETES, 2001, 50 : A302 - A302
  • [29] MECHANISMS OF TRIGLYCERIDE-LOWERING EFFECT OF AN HMG-COA REDUCTASE INHIBITOR IN A HYPERTRIGLYCERIDEMIC ANIMAL-MODEL, THE ZUCKER OBESE RAT
    KASIM, SE
    LEBOEUF, RC
    KHILNANI, S
    TALLAPAKA, L
    DAYANANDA, D
    JEN, KLC
    JOURNAL OF LIPID RESEARCH, 1992, 33 (01) : 1 - 7
  • [30] The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients
    Kim, Tong Min
    Kim, Hyunah
    Jeong, Yoo Jin
    Baik, Sun Jung
    Yang, So Jung
    Lee, Seung-Hwan
    Cho, Jae-Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Choi, In Young
    Yoon, Kun-Ho
    Kim, Hun-Sung
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (10) : 1156 - 1163
12345